ANNOUNCE: UK meeting - Prospects for Immunotherapy

Stephen Young S.P.Young at
Fri May 12 06:14:07 EST 1995

West Midlands Immunology Group - Minisymposium

Prospects for Immunotherapy - 31st May 1995

12.30-5.30pm University of Birmingham Medical School/Hospital


David Kerr (Birmingham)		Immunomodulators in cancer:
				Clinical perspectives

Herman Waldmann (Oxford)	Prospects for increasing the
				specificity of immunosuppression

Peter Searle (Birmingham)	Prospects for immunotherapy of
				cancer by gene therapy

Martin Glennie (Southampton)	Activation and expansion of
				cytotoxic T cells in vitro and
				in vivo using bispecific and
				trispecific antibodies

Adrian Robins (Nottingham)	Anti-idiotypic immunisation in
				colorectal cancer

Eric Culbert (Zeneca)		Immunotherapy of autoimmune
				disease by MHC class II blockade

All are welcome to attend this half day symposium organised by 
the West Midlands Regional Immunology Group of the British 
Society for Immunology. The meeting starts with a buffet lunch 
provided with the help of our sponsors (BSI, R&D Systems, 
Cambridge Bioscience, Promega, Pfizer, Becton Dickinson, Vector 
Laboratories, Advanced Protein Products and Serotec).

There is no registration fee but advanced registration is needed 
so we can guage the demand for lunch etc.

Enquiries and registration to Steve Young, Chair WMRIG: 
s.p.young at
Dr Stephen Young                   |   s.p.young at
Department of Rheumatology         |   tel: +44-(0)-121-414-6480 
University of Birmingham           |   fax: +44-(0)-121-414-6794
Edgbaston                          |   
Birmingham B15 2TT, UK             |                     

More information about the Immuno mailing list